Stem Cell Transplantation for Metastatic Solid Tumors
Status:
Completed
Trial end date:
2020-08-13
Target enrollment:
Participant gender:
Summary
The goal of this research study is to identify other types of cancer (malignant neoplasms)
that may be treatable with stem cell transplantation (allogenic peripheral blood stem cell
transplantation.
Patients with a variety of different types of cancerous tumors that have spread
(metastasized) and whose conditions have not improved with stand therapy, will be eligible to
participate. Those patients selected to participate in the study will undergo a procedure
known as a "mini-transplant". The mini-transplant is a transplantation of stem-cells
collected from a sibling (brother or sister) of the patient. Unlike traditional bone marrow
transplants, the mini-transplant does not require intense chemotherapy or radiation therapy.
Because of this, patients experience fewer and less severe side effects.
This study is open to patients diagnosed with a variety of metastatic solid tumors including
esophageal, gastric (stomach), colon, rectal, liver tumors (hepatoma), cancer of the biliary
system (cholangiocarcinoma), cancer of the pancreas, lung, breast, prostate, bone (sarcoma),
adrenal basal cell, bladder, and adenocarcinomas of unk primary origin.